ELISA – News and Features

This article explores the latest techniques and workflows for purification across biopharmaceuticals including vaccines, monoclonal antibody therapies and gene therapies.

Researchers have uncovered a new phenomenon in graphene research, observing growth-induced self-organized graphene stacking domains that could kick-start the development of advanced quantum technologies.

Researchers have developed synthetic genes that function like the genes in living cells, offering a path toward using a suite of simple building blocks that can be programmed to make complex biomolecular materials.

A team at The University of Texas at El Paso has developed a microfluidic device that can quickly and affordably detect colorectal and prostate cancer. This innovative biochip eliminates the need for expensive equipment.

In this article, explore how next-generation protein sequencing is helping to unlock the proteome.

KRAS inhibitors are showing initial promise in clinical trials, but many tumors quickly develop resistance to the treatment. Now, researchers have discovered a new mechanism of resistance that suggests an opportunity to make the treatment more effective.

The ability to obtain pure proteins is essential for developing drugs, creating vaccines and understanding biological processes. In this article, we discuss what a typical protein purification protocol involves and the various techniques used.

Contamination is a significant issue for bioprocessing as it results in loss of time, money and effort. This article will explore the pivotal role of microbial monitoring in upholding product safety and quality standards within the biopharmaceutical industry.

A new study is the first to measure the transcription of the entire genome in relation to human personality, showing how our personalities influence gene expression.

Rice University researchers have developed a rapid, accurate test for diagnosing malaria that is significantly faster and easier to use than traditional tests.